Hidradenitis suppurativa: Morphologic and vascular study of nodular inflammatory lesions by means of optical coherence tomography

Hidradenitis suppurativa (HS) is an inflammatory disease characterized by a recurrent‐remission trend and clinical lesions that range from asymptomatic to inflamed, deep‐seated nodules with scarring and suppuration. The aim of our study was to identify morphologic and vascular features of HS nodules by means of dynamic optical coherence tomography (D‐OCT) and to define if they are correlated to patient endotype and risk of disease progression. A set of standardized clinical pictures and D‐OCT images were acquired from 57 inflammatory nodules of 40 patients affected by HS. A set of 20 clinical and D‐OCT images were acquired from 20 healthy volunteers as a control group. The comparison of D‐OCT features among HS and control group was analysed. The correlation between HS patient endotype and D‐OCT features of the lesions was calculated. D‐OCT enabled to identify vascular and morphological aspects characterizing HS nodular inflammatory lesions. In addition, several D‐OCT features were significantly different among distinct disease endotypes. The characterization of HS nodular inflammatory lesions through D‐OCT, corresponding to blood vessel dilation and inflammatory associated hyper‐vascularization, may have important clinical consequences in the assessment of HS risk of progression, therapeutic decisions and treatment efficacy monitoring.

[1]  R. Pampena,et al.  Dermoscopy, confocal microscopy and optical coherence tomography features of main inflammatory and autoimmune skin diseases: A systematic review , 2021, The Australasian journal of dermatology.

[2]  C. Longo,et al.  Real-Time Confocal Imaging for Hidradenitis Suppurativa: Description of Morphological Aspects and Focus on the Role of Follicular Ostia , 2021, Dermatology.

[3]  E. Candi,et al.  Clinical and Power‐Doppler ultrasound features related with persistence of fistulous tracts under treatment with adalimumab in hidradenitis suppurativa: 4 years of follow‐up , 2021, Dermatologic therapy.

[4]  T. Montero-Vílchez,et al.  Implications of Hidradenitis Suppurativa Phenotypes in Cardiovascular Risk and Treatment Decisions: A Retrospective Cohort Study , 2021, Dermatology.

[5]  R. Sabat,et al.  Aetiology and pathogenesis of hidradenitis suppurativa , 2020, The British journal of dermatology.

[6]  J. Ingram The epidemiology of hidradenitis suppurativa * , 2020, The British journal of dermatology.

[7]  X. Wortsman Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa , 2020, The British journal of dermatology.

[8]  G. Jemec,et al.  Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  X. Wortsman Color Doppler ultrasound: a standard of care in hidradenitis suppurativa , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  G. Pellacani,et al.  Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab , 2020, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[11]  G. Pellacani,et al.  Surgical and postsurgical wound care in hidradenitis suppurativa , 2020, Dermatologic therapy.

[12]  A. Martorell,et al.  Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  G. Pellacani,et al.  Nodular skin lesions: correlation of reflectance confocal microscopy and optical coherence tomography features , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  A. Martorell,et al.  Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  G. Pellacani,et al.  The evolution of healthy skin to acne lesions: a longitudinal, in vivo evaluation with reflectance confocal microscopy and optical coherence tomography , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  J. Krueger,et al.  Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa , 2019, Experimental dermatology.

[17]  A. Gottlieb,et al.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. , 2019, Journal of the American Academy of Dermatology.

[18]  C. Carillo,et al.  Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  L. Bianchi,et al.  Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  C. Ahn,et al.  An update on the pathogenesis of hidradenitis suppurativa: implications for therapy , 2018, Expert review of clinical immunology.

[21]  D. Presser,et al.  Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity , 2017, The British journal of dermatology.

[22]  G. Pellacani,et al.  Acne: morphologic and vascular study of lesions and surrounding skin by means of optical coherence tomography , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  J. Jais,et al.  The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Y. Lévy,et al.  Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. , 2016, The Journal of investigative dermatology.

[25]  C. Grana,et al.  Dynamic Optical Coherence Tomography in Dermatology , 2016, Dermatology.

[26]  G. Jemec,et al.  New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. , 2015, Journal of the American Academy of Dermatology.

[27]  J. Lapins,et al.  European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  X. Wortsman,et al.  Ultrasound In‐Depth Characterization and Staging of Hidradenitis Suppurativa , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[29]  A. Kimball,et al.  Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa , 2012, Annals of Internal Medicine.

[30]  G. Jemec Clinical practice. Hidradenitis suppurativa. , 2012, The New England journal of medicine.

[31]  J. Wohlrab,et al.  Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae , 2011, The British journal of dermatology.

[32]  J. Lapins,et al.  Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity , 2009, The British journal of dermatology.

[33]  P. Helmbold,et al.  Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis * , 2009, Experimental dermatology.

[34]  A. Alikhan Hidradenitis Suppurativa. , 2016, JAMA dermatology.